Unicycive Therapeutics Stock Price History
| UNCY Stock | USD 0.68 0.03 4.62% |
If you're considering investing in Unicycive Stock, it is important to understand the factors that can impact its price. As of today, the current price of Unicycive Therapeutics stands at 0.68, as last reported on the 22nd of March, with the highest price reaching 0.69 and the lowest price hitting 0.63 during the day. At this stage we consider Unicycive Stock to be dangerous. Unicycive Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0342, which indicates the firm had a 0.0342 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Unicycive Therapeutics, which you can use to evaluate the volatility of the company. Please validate Unicycive Therapeutics' Semi Deviation of 4.33, risk adjusted performance of 0.0386, and Coefficient Of Variation of 2920.04 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%.
Unicycive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Unicycive |
Sharpe Ratio = 0.0342
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | UNCY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.06 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Unicycive Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Unicycive Therapeutics by adding it to a well-diversified portfolio.
Unicycive Therapeutics Stock Price History Chart
There are several ways to analyze Unicycive Stock price data. The simplest method is using a basic Unicycive candlestick price chart, which shows Unicycive Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 30, 2024 | 0.81 |
| Lowest Price | March 3, 2025 | 0.52 |
Unicycive Therapeutics March 22, 2025 Stock Price Synopsis
Various analyses of Unicycive Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Unicycive Stock. It can be used to describe the percentage change in the price of Unicycive Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Unicycive Stock.| Unicycive Therapeutics Price Action Indicator | 0.04 | |
| Unicycive Therapeutics Price Daily Balance Of Power | 0.50 | |
| Unicycive Therapeutics Price Rate Of Daily Change | 1.05 |
Unicycive Therapeutics March 22, 2025 Stock Price Analysis
Unicycive Stock Price History Data
The price series of Unicycive Therapeutics for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 0.29 with a coefficient of variation of 12.84. The daily prices for the period are distributed with arithmetic mean of 0.62. The median price for the last 90 days is 0.6.| Open | High | Low | Close | Volume | ||
03/22/2025 | 0.64 | 0.69 | 0.63 | 0.68 | ||
| 03/21/2025 | 0.64 | 0.69 | 0.63 | 0.68 | 1,858,246 | |
| 03/20/2025 | 0.66 | 0.68 | 0.63 | 0.65 | 959,358 | |
| 03/19/2025 | 0.59 | 0.68 | 0.59 | 0.66 | 1,687,470 | |
| 03/18/2025 | 0.57 | 0.60 | 0.57 | 0.60 | 481,600 | |
| 03/17/2025 | 0.59 | 0.60 | 0.57 | 0.58 | 443,470 | |
| 03/14/2025 | 0.59 | 0.60 | 0.57 | 0.59 | 267,150 | |
| 03/13/2025 | 0.59 | 0.59 | 0.56 | 0.58 | 379,618 | |
| 03/12/2025 | 0.59 | 0.60 | 0.56 | 0.59 | 276,707 | |
| 03/11/2025 | 0.53 | 0.59 | 0.53 | 0.58 | 461,163 | |
| 03/10/2025 | 0.56 | 0.58 | 0.53 | 0.54 | 600,575 | |
| 03/07/2025 | 0.55 | 0.58 | 0.53 | 0.56 | 353,788 | |
| 03/06/2025 | 0.56 | 0.60 | 0.54 | 0.55 | 1,042,800 | |
| 03/05/2025 | 0.51 | 0.57 | 0.50 | 0.56 | 414,307 | |
| 03/04/2025 | 0.51 | 0.53 | 0.47 | 0.52 | 1,453,885 | |
| 03/03/2025 | 0.53 | 0.56 | 0.52 | 0.52 | 653,728 | |
| 02/28/2025 | 0.56 | 0.57 | 0.45 | 0.55 | 1,140,095 | |
| 02/27/2025 | 0.57 | 0.58 | 0.56 | 0.56 | 284,003 | |
| 02/26/2025 | 0.56 | 0.57 | 0.54 | 0.57 | 332,542 | |
| 02/25/2025 | 0.56 | 0.57 | 0.53 | 0.54 | 614,606 | |
| 02/24/2025 | 0.61 | 0.64 | 0.56 | 0.57 | 1,511,440 | |
| 02/21/2025 | 0.62 | 0.65 | 0.59 | 0.62 | 1,380,317 | |
| 02/20/2025 | 0.60 | 0.62 | 0.57 | 0.61 | 1,273,500 | |
| 02/19/2025 | 0.61 | 0.62 | 0.59 | 0.60 | 624,460 | |
| 02/18/2025 | 0.60 | 0.65 | 0.60 | 0.62 | 1,744,200 | |
| 02/14/2025 | 0.57 | 0.60 | 0.55 | 0.59 | 726,853 | |
| 02/13/2025 | 0.53 | 0.56 | 0.51 | 0.56 | 910,096 | |
| 02/12/2025 | 0.53 | 0.54 | 0.52 | 0.53 | 426,100 | |
| 02/11/2025 | 0.56 | 0.56 | 0.53 | 0.53 | 591,283 | |
| 02/10/2025 | 0.56 | 0.63 | 0.53 | 0.54 | 2,605,400 | |
| 02/07/2025 | 0.60 | 0.61 | 0.56 | 0.57 | 685,878 | |
| 02/06/2025 | 0.63 | 0.64 | 0.60 | 0.61 | 571,031 | |
| 02/05/2025 | 0.62 | 0.65 | 0.60 | 0.63 | 952,982 | |
| 02/04/2025 | 0.62 | 0.64 | 0.58 | 0.60 | 769,600 | |
| 02/03/2025 | 0.59 | 0.63 | 0.58 | 0.60 | 1,138,400 | |
| 01/31/2025 | 0.58 | 0.64 | 0.58 | 0.61 | 1,427,300 | |
| 01/30/2025 | 0.53 | 0.58 | 0.52 | 0.58 | 1,054,400 | |
| 01/29/2025 | 0.53 | 0.54 | 0.52 | 0.53 | 604,000 | |
| 01/28/2025 | 0.58 | 0.59 | 0.51 | 0.54 | 1,383,600 | |
| 01/27/2025 | 0.59 | 0.62 | 0.55 | 0.57 | 939,000 | |
| 01/24/2025 | 0.62 | 0.63 | 0.59 | 0.60 | 979,500 | |
| 01/23/2025 | 0.63 | 0.64 | 0.62 | 0.63 | 454,708 | |
| 01/22/2025 | 0.65 | 0.66 | 0.62 | 0.62 | 620,955 | |
| 01/21/2025 | 0.63 | 0.66 | 0.62 | 0.65 | 475,227 | |
| 01/17/2025 | 0.61 | 0.65 | 0.61 | 0.62 | 586,385 | |
| 01/16/2025 | 0.66 | 0.67 | 0.61 | 0.61 | 1,269,144 | |
| 01/15/2025 | 0.68 | 0.68 | 0.63 | 0.67 | 1,125,572 | |
| 01/14/2025 | 0.69 | 0.73 | 0.65 | 0.66 | 851,276 | |
| 01/13/2025 | 0.65 | 0.72 | 0.58 | 0.69 | 1,955,046 | |
| 01/10/2025 | 0.74 | 0.74 | 0.65 | 0.66 | 1,936,926 | |
| 01/08/2025 | 0.78 | 0.78 | 0.72 | 0.74 | 1,651,642 | |
| 01/07/2025 | 0.76 | 0.79 | 0.69 | 0.78 | 2,373,927 | |
| 01/06/2025 | 0.78 | 0.78 | 0.73 | 0.76 | 1,139,443 | |
| 01/03/2025 | 0.82 | 0.83 | 0.76 | 0.78 | 998,109 | |
| 01/02/2025 | 0.80 | 0.81 | 0.75 | 0.79 | 1,165,675 | |
| 12/31/2024 | 0.83 | 0.83 | 0.78 | 0.79 | 1,014,212 | |
| 12/30/2024 | 0.82 | 0.83 | 0.78 | 0.81 | 1,319,106 | |
| 12/27/2024 | 0.80 | 0.81 | 0.73 | 0.80 | 1,192,918 | |
| 12/26/2024 | 0.70 | 0.79 | 0.70 | 0.79 | 1,886,503 | |
| 12/24/2024 | 0.67 | 0.68 | 0.63 | 0.67 | 599,126 | |
| 12/23/2024 | 0.70 | 0.70 | 0.64 | 0.66 | 1,231,865 |
About Unicycive Therapeutics Stock history
Unicycive Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Unicycive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Unicycive Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Unicycive Therapeutics stock prices may prove useful in developing a viable investing in Unicycive Therapeutics
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. The company was incorporated in 2016 and is based in Los Altos, California. Unicycive Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
Unicycive Therapeutics Stock Technical Analysis
Unicycive Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Unicycive Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Unicycive Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Unicycive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Unicycive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0386 | |||
| Jensen Alpha | 0.2241 | |||
| Total Risk Alpha | 0.5474 | |||
| Sortino Ratio | 0.0486 | |||
| Treynor Ratio | 0.1806 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Unicycive Stock Analysis
When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.